SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CRVS

Corvus Pharmaceuticals Inc.
NASDAQHealth Care

Latest close: 9.52 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 6, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 6, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Jul 22, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record55421 flagged findings
Reported transactions (Form 4)66since May 15, 2023 · and 1 other holding
Corporate events (8-K)28since Dec 8, 2016

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…stock warrants for net proceeds of approximately $30.3 million and proceeds of $54.3 million from the exercise of common stock…”
    +1 more passage from the same document
    • “…As of March 31, 2026, no dividends on common stock had been declared. ​ On August 6, 2024, the Company entered into an Open…”
  • 2026-05-07listing compliance noticerecentOpen filing ↗
    “…stock. Such litigation, if instituted against us, could cause us to incur substantial costs and divert management’s attention…”
    +1 more passage from the same document
    • “…attention and resources, which could have a material adverse effect on our business, financial condition and results of…”
  • 2026-05-07regulatory investigationrecentOpen filing ↗
    “…The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has…”
  • 2026-05-07Department of Justice inquiryrecentOpen filing ↗
    “…be sufficient in all circumstances and that transfers must be assessed on a case-by-case basis. On July 10, 2023, the European…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 554)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Aug 7, 26SCHEDULE 13G ↗Passive stake · STATE STREET CORPORATION · 5.3% · event on Jun 30, 26
  • Aug 6, 268-K ↗Current report · Results
  • Aug 6, 2610-Q ↗Quarterly report
  • Jul 27, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 7.5% · event on Jun 30, 26 · amendment
  • Jul 22, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Jun 12, 268-K ↗Current report · Shareholder vote results
  • May 20, 26Form 4 ↗Insider transaction
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • May 15, 26SCHEDULE 13G ↗Passive stake · Sirenia Capital Management LP · 7.5% · event on Mar 31, 26
  • May 14, 268-K ↗Current report · Communication to the market · Other events
  • May 7, 268-K ↗Current report · Results
  • May 7, 2610-Q ↗Quarterly report
  • Apr 27, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 6.4% · event on Mar 31, 26 · amendment
  • Apr 27, 26Form 4 ↗Insider transaction
  • Apr 27, 26Form 3 ↗Insider transaction
  • Apr 24, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 24, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 23, 268-K ↗Current report · A senior executive left or was appointed
  • Mar 26, 26SCHEDULE 13G/A ↗Passive stake · amendment
  • Mar 13, 268-K ↗Current report · Entered a material agreement

554 filings on record, the oldest from Dec 7, 15.

Listing the 25 most recent filings of the 554 on record.

8-Ks, explained

Stress1Structure11Governance16
  • Jul 22, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 23, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 13, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Oct 2, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 9, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 23, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • May 6, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jan 23, 24GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 3, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 29, 23StructureA material agreement was terminated8-K 1.02 ↗
  • Oct 28, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Nov 2, 21StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

14 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • ORBIMED ADVISORS LLC10.3%Jan 23, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Adams Street Partners, LLC3.9%Jan 23, 26SCHEDULE 13D/A ↗10 co-filers on this document — the figure is the largest single stake, not their sum.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Richard A. Miller7.8%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • BlackRock, Inc.7.5%Jun 30, 26SCHEDULE 13G/A ↗2 earlier filings
  • Sirenia Capital Management LP7.5%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • SAMLYN CAPITAL, LLC6.0%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • STATE STREET CORPORATION5.3%Jun 30, 26SCHEDULE 13G ↗
show one more holderhide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 11, 26Buy$250KDavid Scott Moore↗
  • May 18, 26Buy$60KRICHARD A MILLER MDPresident and CEO↗
  • May 18, 26Buy$23KRICHARD A MILLER MDPresident and CEO↗
  • Jun 27, 25Sell$4.9MPeter A. Thompson↗
  • Jun 27, 25Sell$4.9MORBIMED ADVISORS LLC↗
  • May 6, 24Buy$1000KRICHARD A MILLER MDPresident and CEO↗
  • May 6, 24Buy$35KWilliam Benton JonesSee Remarks↗
  • May 15, 23Buy$25KLinda Grais↗
Stock compensation, tax and giftsshow the 18 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jan 28, 26Compensation$450KPeter A. Thompson↗
  • Jan 28, 26Compensation$146KPeter A. Thompson↗
  • Jan 28, 26Compensation$188KPeter A. Thompson↗
  • Jan 28, 26Compensation$54KPeter A. Thompson↗
  • Jan 28, 26Compensation$30KPeter A. Thompson↗
  • Jan 28, 26Compensation$49KPeter A. Thompson↗
  • Jan 28, 26Compensation$41KPeter A. Thompson↗
  • Jan 28, 26Compensation$39KPeter A. Thompson↗
  • Jan 28, 26Compensation$15KPeter A. Thompson↗
  • Jan 28, 26Compensation$14KPeter A. Thompson↗
  • Jan 28, 26Compensation$37KPeter A. Thompson↗
  • Jan 28, 26Compensation$25KPeter A. Thompson↗
  • Jan 28, 26Compensation$32KPeter A. Thompson↗
  • Jun 27, 25Other$4.9MPeter A. Thompson↗
  • Jun 27, 25Other$4.9MORBIMED ADVISORS LLC↗
  • Jun 4, 25Compensation$68KWilliam Benton JonesSee Remarks↗
  • May 7, 25Compensation$2.0MRICHARD A MILLER MDPresident and CEO↗
  • May 10, 24Giftamount n/aRICHARD A MILLER MDPresident and CEO↗

The full record holds 26 transactions and goes back to Mar 31, 23.

Its sector and its market

Corvus Pharmaceuticals Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Corvus Pharmaceuticals Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Corvus Pharmaceuticals Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
554 documents on file, from Dec 7, 2015 to Aug 7, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.